|
1
|
Andreoli MCC and Totoli C: Peritoneal
dialysis. Rev Assoc Med Bras (1992). 66 (Suppl 1):S37–S44.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Thongprayoon C, Wathanavasin W,
Suppadungsuk S, Davis PW, Miao J, Mao MA, Craici IM, Qureshi F and
Cheungpasitporn W: Assessing global and regional public interest in
home dialysis modalities from 2004 to 2024. Front Nephrol.
4(1489180)2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Perl J, Brown EA, Chan CT, Couchoud C,
Davies SJ, Kazancioğlu R, Klarenbach S, Liew A, Weiner DE, Cheung
M, et al: Home dialysis: Conclusions from a Kidney Disease:
Improving Global Outcomes (KDIGO) Controversies Conference. Kidney
Int. 103:842–858. 2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Cho Y, Cullis B, Ethier I, Htay H, Jha V,
Arruebo S, Caskey FJ, Damster S, Donner JA, Levin A, et al: Global
structures, practices, and tools for provision of chronic
peritoneal dialysis. Nephrol Dial Transplant. 39 (Suppl
1):ii18–ii25. 2024.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Liu X, Qin A, Zhou H, He X, Cader S, Wang
S, Tang Y and Qin W: Novel predictors and risk score of treatment
failure in peritoneal Dialysis-related peritonitis. Front Med
(Lausanne). 8(639744)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Perl J, Davies SJ, Lambie M, Pisoni RL,
McCullough K, Johnson DW, Sloand JA, Prichard S, Kawanishi H,
Tentori F and Robinson BM: The peritoneal dialysis outcomes and
practice patterns study (PDOPPS): Unifying efforts to inform
practice and improve global outcomes in peritoneal dialysis. Perit
Dial Int. 36:297–307. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li PK, Chow KM, Cho Y, Fan S, Figueiredo
AE, Harris T, Kanjanabuch T, Kim YL, Madero M, Malyszko J, et al:
ISPD peritonitis guideline recommendations: 2022 update on
prevention and treatment. Perit Dial Int. 42:110–153.
2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Li PKT, Szeto CC, Piraino B, de Arteaga J,
Fan S, Figueiredo AE, Fish DN, Goffin E, Kim YL, Salzer W, et al:
ISPD peritonitis recommendations: 2016 update on prevention and
treatment. Perit Dial Int. 36:481–508. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mao Y, Xiao D, Deng S and Xue S:
Development of a clinical risk score system for peritoneal
dialysis-associated peritonitis treatment failure. BMC Nephrol.
24(229)2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li J, Liu Y, Lu Y, Fu C, Ye Z and Zhang Z:
Dynamic changes in serum albumin and ferritin indicate higher risk
of early-onset peritonitis in peritoneal dialysis patients. Ther
Apher Dial: Jan 2, 2025 (Epub ahead of print). doi:
10.1111/1744-9987.14244.
|
|
11
|
Meng L, Zhu X, Yang L, Li X, Cheng S, Guo
S, Zhuang X, Zou H and Cui W: Development and validation of a
prediction model for treatment failure in peritoneal
dialysis-associated peritonitis patients: A multicenter study. Nan
Fang Yi Ke Da Xue Xue Bao. 42:546–553. 2022.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
12
|
Htay H, Cho Y, Pascoe EM, Darssan D,
Nadeau-Fredette AC, Hawley C, Clayton PA, Borlace M, Badve SV, Sud
K, et al: Center effects and peritoneal dialysis peritonitis
outcomes: Analysis of a national registry. Am J Kidney Dis.
71:814–821. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Su N, Zheng Y, Zhang X, Tang X, Tang LW,
Wang Q, Chen X, Wang X, Wen Y, Feng X, et al:
Platelet-to-lymphocyte ratio and the first occurrence of
peritonitis in peritoneal dialysis patients. BMC Nephrol.
23(415)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li G, Yu J, Jiang S, Wu K, Xu Y, Lu X,
Wang Y, Lin J, Yang X, Li Z, et al: Systemic immune-inflammation
index was significantly associated with all-cause and
cardiovascular-specific mortalities in patients receiving
peritoneal dialysis. J Inflamm Res. 16:3871–3878. 2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yang Y, Xu Y, Liu S, Lu P, Zhou H and Yang
M: The systemic inflammation indexes predict all-cause mortality in
peritoneal dialysis patients. Renal failure.
45(2160348)2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tripodi A and Di Micco P: How we manage a
high D-dimer. Haematologica. 109:933–943. 2024.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cerda-Mancillas MC, Santiago-Germán D,
Andrade-Bravo B, Pedraza-Olivares F, Valenzo-Hernández F,
Leaños-Miranda A and Isordia-Salas I: D-dimer as a biomarker of
severity and adverse outcomes in patients with community acquired
pneumonia. Arch Med Res. 51:429–435. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Schupp T, Weidner K, Rusnak J, Jawhar S,
Forner J, Dulatahu F, Brück LM, Hoffmann U, Kittel M, Bertsch T, et
al: D-Dimer levels and the disseminated intravascular coagulation
score to predict severity and outcomes in sepsis or septic shock.
Clin Lab: May 1, 2023 (Epub ahead of print). doi:
10.7754/Clin.Lab.2022.221015.
|
|
19
|
Dumache R, Muresan CO, Laitin SMD,
Ivanovic N, Chisalita A, Herlo A, Marinescu A, Lazureanu EV and Cut
TG: COVID-19 organ injury pathology and D-Dimer expression
patterns: A retrospective analysis. Diagnostics (Basel).
15(1860)2025.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Balaceanu LA and Dina I: D-dimers in
advanced liver cirrhosis: Useful biomarker or not? Am J Med Sci.
368:415–423. 2024.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Fiusa MM, Carvalho-Filho MA,
Annichino-Bizzacchi JM and De Paula EV: Causes and consequences of
coagulation activation in sepsis: An evolutionary medicine
perspective. BMC Medicine. 13(105)2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Doganyigit Z, Eroglu E and Akyuz E:
Inflammatory mediators of cytokines and chemokines in sepsis: From
bench to bedside. Hum Exp Toxicol.
41(9603271221078871)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Levi M and van der Poll T: Inflammation
and coagulation. Crit Care Med. 38 (Suppl 2):S26–S34.
2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
De Backer D, Orbegozo Cortés D, Donadello
K and Vincent JL: Pathophysiology of microcirculatory dysfunction
and the pathogenesis of septic shock. Virulence. 5:73–79.
2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Iba T, Helms J and Levy JH: Sepsis-induced
coagulopathy (SIC) in the management of sepsis. Ann Intensive Care.
14(148)2024.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Qi Q, Zhuang L, Shen Y, Geng Y, Yu S, Chen
H, Liu L, Meng Z, Wang P and Chen Z: A novel systemic inflammation
response index (SIRI) for predicting the survival of patients with
pancreatic cancer after chemotherapy. Cancer. 122:2158–2167.
2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wei Y, Wang T, Li G, Feng J, Deng L, Xu H,
Yin L, Ma J, Chen D and Chen J: Investigation of systemic
immune-inflammation index, neutrophil/high-density lipoprotein
ratio, lymphocyte/high-density lipoprotein ratio, and
monocyte/high-density lipoprotein ratio as indicators of
inflammation in patients with schizophrenia and bipolar disorder.
Front Psychiatry. 13(941728)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Agnello L, Giglio RV, Bivona G, Scazzone
C, Gambino CM, Iacona A, Ciaccio AM, Lo Sasso B and Ciaccio M: The
value of a complete blood count (CBC) for sepsis diagnosis and
prognosis. Diagnostics (Basel). 11(1881)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang Z, Zhang W, Chen L, Lu X and Tu Y:
Lymphopenia in sepsis: A narrative review. Crit Care.
28(315)2024.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Li J, Li Y, Zou Y, Chen Y, He L, Wang Y,
Zhou J, Xiao F, Niu H and Lu L: Use of the systemic inflammation
response index (SIRI) as a novel prognostic marker for patients on
peritoneal dialysis. Ren Fail. 44:1227–1235. 2024.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Gu L, Xia Z, Qing B, Wang W, Chen H, Wang
J, Chen Y, Gai Z, Hu R and Yuan Y: Systemic inflammatory response
index (SIRI) is associated with all-cause mortality and
cardiovascular mortality in population with chronic kidney disease:
Evidence from NHANES (2001-2018). Front Immunol.
15(1338025)2024.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Lopes MB, Karaboyas A, Zhao J, Johnson DW,
Kanjanabuch T, Wilkie M, Nitta K, Kawanishi H, Perl J and Pisoni
RL: PDOPPS Steering Committee. Association of single and serial
measures of serum phosphorus with adverse outcomes in patients on
peritoneal dialysis: Results from the international PDOPPS. Nephrol
Dial Transplant. 38:193–202. 2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Liu CT, Lin YC, Lin YC, Kao CC, Chen HH,
Hsu CC and Wu MS: Roles of serum calcium, phosphorus, PTH and ALP
on mortality in peritoneal dialysis patients: A nationwide,
population-based longitudinal study. Sci Rep. 7(33)2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Huo Z, Liu D, Ye P, Zhang Y, Cao L, Gong
N, Dou X, Ren C, Zhu Q, Li D, et al: Longer serum phosphorus time
in range is associated with lower mortality risk among peritoneal
dialysis patients: A multicenter cohort study. BMC Nephrol.
25(117)2024.PubMed/NCBI View Article : Google Scholar
|
|
35
|
White KE and Ix JH: Regulation of FGF23
production and phosphate metabolism. Nat Rev Nephrol. 19:185–193.
2023.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Fitzpatrick EA, Han X, Xiao Z and Quarles
LD: Role of fibroblast growth Factor-23 in innate immune responses.
Front Endocrinol (Lausanne). 9(320)2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Rossaint J, Oehmichen J, Van Aken H,
Reuter S, Pavenstädt HJ, Meersch M, Unruh M and Zarbock A: FGF23
signaling impairs neutrophil recruitment and host defense during
CKD. J Clin Invest. 126:962–974. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
38
|
Han X, Li L, Yang J, King G, Xiao Z and
Quarles LD: Counter-regulatory paracrine actions of FGF-23 and
1,25(OH)2 D in macrophages. FEBS Lett. 590:53–67. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Raju S and Saxena R: Hyperphosphatemia in
kidney failure: Pathophysiology, challenges, and critical role of
phosphorus management. Nutrients. 17(1587)2025.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Yamada S, Tokumoto M, Tatsumoto N,
Taniguchi M, Noguchi H, Nakano T, Masutani K, Ooboshi H, Tsuruya K
and Kitazono T: Phosphate overload directly induces systemic
inflammation and malnutrition as well as vascular calcification in
uremia. Am J Physiol Renal Physiol. 306:F1418–F1428.
2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Voelkl J, Lang F, Eckardt KU, Amann K,
Kuro OM, Pasch A, Pieske B and Alesutan I: Signaling pathways
involved in vascular smooth muscle cell calcification during
hyperphosphatemia. Cell Mol Life Sci. 76:2077–2091. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Zha D, Yang X and Xi H: Association of
hypoalbuminemia with the risk of peritoneal dialysis-associated
peritonitis in peritoneal dialysis patients: A meta-analysis. Blood
Purif: Feb 10, 2025 (Epub ahead of print). doi:
10.1159/000543693.
|
|
43
|
Zhang L, Cao T, Li Z, Wen Q, Lin J, Zhang
X, Guo Q, Yang X, Yu X and Mao H: Clinical outcomes of peritoneal
dialysis patients transferred from hemodialysis: A matched
case-control study. Perit Dial Int. 33:259–266. 2013.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Arques S: Human serum albumin in
cardiovascular diseases. Eur J Intern Med. 52:8–12. 2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Soeters PB, Wolfe RR and Shenkin A:
Hypoalbuminemia: Pathogenesis and clinical significance. JPEN J
Parenter Enteral Nutr. 43:181–193. 2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
van Smeden M, Moons KGM, de Groot JAH,
Collins GS, Altman DG, Eijkemans MJ and Reitsma JB: Sample size for
binary logistic prediction models: Beyond events per variable
criteria. Stat Methods Med Res. 28:2455–2474. 2018.PubMed/NCBI View Article : Google Scholar
|
